Company Overview of Lumavita AG
Lumavita AG, a biopharmaceutical company, engages in the development and commercialization of novel anti-infectives for women's health. Its products include FemiFect, an antibiotic to treat infections known to cause vaginitis, such as bacteria, fungi, and protozoa; and SPK-601 that is for the treatment of human papilloma virus (HPV) and herpes simplex virus (HSV). The company markets its products through distributors. Lumavita AG was founded in 2008 and is based in Basel, Switzerland.
Founded in 2008
41 61 225 41 02
Key Executives for Lumavita AG
Similar Private Companies By Industry
|Abbott Service AG||Europe|
|Pike Pharma GmbH||Europe|
|Novartis Pharma Schweizerhalle AG||Europe|
|BASF Pharma (Evionnaz) SA||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Lumavita AG, please visit www.lumavita.com. Company data is provided by Capital IQ. Please use this form to report any data issues.